U.S. adults who received the recommended doses of the HPV vaccine 2013-2018 by gender
In 2019, around 35 percent of U.S. females aged 18 to 26 years stated they had received the recommended number of doses for HPV, compared to just 9 percent of males. The statistic illustrates the share of adults aged 18-26 in the U.S. who had received the recommended number of doses of human papillomavirus vaccine between 2013 and 2018, by gender.